Senstar Technologies Ltd. - Ordinary Shares SNT 深 沪
等待开盘 07-22 09:30:00 美东时间
4.33
-0.210
-4.63%
华盛通- 最 高4.59
- 今 开4.54
- 成交量 5.15万股
- 最 低 4.311
- 昨 收 4.54
- 总市值 1.01亿
- 52周最高 5.04
- 市盈率 静 26.35
- 换手率 0.00%
- 52周最低 1.40
- 委 比 46.62%
- 总股本 2332.67万
- 历史最高 5.196
- 量 比 0.73
- 振 幅 6.15%
- 历史最低 -0.624
- 每 手 1
- 风险率 1.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Syntara’s Amsulostat Receives WHO INN Recognition, Boosting Myelofibrosis Treatment Prospects
Pharmaxis Ltd ( ($AU:SNT) ) has provided an announcement. Syntara Limited annou...
07-08 07:09
Syntara Limited Issues Unquoted Performance Rights
An announcement from Pharmaxis Ltd ( ($AU:SNT) ) is now available. Syntara Limi...
07-02 10:27
BVF Partners L.P. Reduces Stake in Syntara Limited
Pharmaxis Ltd ( ($AU:SNT) ) has provided an update. BVF Partners L.P., along wi...
06-23 07:27
Senti Bio Granted U.S. FDA Orphan Drug Designation for Use of First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202 to Treat Acute Myeloid Leukemia
Senti Biosciences announced that the FDA has granted Orphan Drug Designation to SENTI-202 for the treatment of relapsed/refractory acute myeloid leukemia (AML). SENTI-202, a first-in-class off-the-shelf CAR NK cell therapy, targets CD33 and FLT3-expressing hematologic malignancies while sparing healthy cells. With 20,800 new AML cases in the U.S. annually and a dismal median survival rate, the designation underscores the need for innovative treat...
06-18 11:00
Senti Biosciences Announces New Employment Inducement Grants
Senti Bio, a biotechnology company, recently awarded stock options to eight new employees, granting them the right to purchase 102,500 shares at $3.03 per share under its 2022 equity plan. The company focuses on developing cell and gene therapies for incurable diseases using its Gene Circuit platform, targeting challenging tumor indications.
06-09 20:30
Senstar Tech Q1 EPS $0.04 Up From $(0.03) YoY, Sales $8.45M Up From $7.51M YoY
Senstar Tech (NASDAQ:SNT) reported quarterly earnings of $0.04 per share. This is a 233.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported $8.45 million in sales
05-28 04:10
Earnings Scheduled For May 27, 2025
Companies Reporting Before The Bell • Bank of Nova Scotia (NYSE:BNS) is project...
05-27 16:32
Earnings Scheduled For April 23, 2025
Companies Reporting Before The Bell • GATX (NYSE:GATX) is estimated to report q...
04-23 16:32
Earnings Scheduled For November 12, 2024
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is likel...
2024-11-12 16:32
Senstar Technologies Completes Corporate Redomiciliation from Israel to Canada
Ottawa, ON, March 18, 2024 /PRNewswire/ -- Senstar Technologies Corporation (NASDAQ: SNT), a leading international provider of comprehensive physical, video and access control security produ...
2024-03-19 04:05
